“Hard to Reach” Is a Sponsor Operations Failure, Not a Population Problem
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...
Site Selection
AI Site Selection Sounds Fast — Until You See What Happens After the Algorithm Picks Your Site
ASCO and Ryght AI are using algorithms to select CDK4/6 inhibitor trial sites. Here's what ops teams need to...
When AI Picks Your Site, Execution Still Happens in the Building
ASCO and Ryght AI are using machine learning to select breast cancer trial sites. Here's what that means for...
AbbVie: Predictive Analytics Breakthrough in Site Selection
During the recent SCOPE Summit Europe 2023, a venue for experts to dissect the complexities of clinical trials, Kieran...